Submissions

Author Guidelines

Individuals designated as authors must have made a substantial contribution to the development of the manuscript. REUFPI adopts authorship criteria as per the Uniform Disclosure Form for Potential Conflicts of Interest (ICMJE), which include: a) substantial contributions to the conception or design of the work; b) acquisition, analysis, or interpretation of data; c) drafting the article or critically revising it; d) final approval of the version to be published. The maximum number of authors is seven. Exceptionally, for multicenter studies, the inclusion of additional authors will be considered based on the relevance of the justification. Co-authors who do not meet these criteria should not be included.

A REUFPI não aceita mais de dois artigos publicados por edição da revista.

The corresponding author must gather all necessary documentation (checklist) and follow these steps:

• Choose the appropriate section for submission. For more information, click here;
• Submission language (Portuguese, Spanish, or English);
• Comments to the editor (Cover letter) – a letter to the Editor must be presented, justifying the importance of the manuscript for publication in REUFPI, highlighting the contribution of the results to knowledge advancement and applicability in practice;

Completing the metadata is mandatory; without it, the manuscript cannot proceed to the first review stage. All requested information must be accurately filled out:

• Author(s): Full names (no abbreviations), email, ORCiD, Lattes URL, institution/affiliation, country, biography (highest academic degree and institutional affiliation);
• Title: up to 15 words, in the manuscript’s language (do not use all caps);
• Abstract: up to 200 words in the manuscript’s language. It must be structured as follows: Objective, Methods, Results, and Conclusion;
• three to five keywords in Portuguese, English, and Spanish. Portuguese and Spanish keywords must be drawn from DECS (http://decs.bvs.br/), and English keywords from MeSH (http://www.nlm.nih.gov/mesh/meshhome.html);
• Contributors and funding agencies: Optional acknowledgment of contributors who are not listed as authors. In the case of funding, authors must cite the supporting agency;
• References: must follow Vancouver Style as outlined by the International Committee of Medical Journal Editors (ICMJE): www.icmje.org.

• Title page (Template)
• o Declaration of Responsibility and Copyright Transfer, signed by all authors and addressed to the Editor-in-Chief (Template)
• o Research involving human subjects in Brazil must present documentation of approval by the Research Ethics Committee and/or CONEP, in accordance with Resolution CNS No. 466/2012, when applicable.

At this stage, the author must review all uploaded documents and finalize the submission.

REUFPI recommends that manuscripts follow the detailed guidelines below:

Manuscripts must be typed using Microsoft Word with the following page setup: A4 size, 2.5 cm margins, Times New Roman font, size 12, 1.5 line spacing throughout the text, and page numbers at the top right.

The manuscript should begin with the title (centered, up to 15 words, not in all caps), followed by the abstract (up to 200 words, structured into Objective, Methods, Results, and Conclusion). Both the title and abstract must be written only in the language of the manuscript.

Keywords should follow the abstract (three to five) in Portuguese (Descritores), English (Descriptors), and Spanish (Descriptores). Portuguese and Spanish terms must come from DECS, and English terms from MeSH.

The manuscript should include the following sections in continuous format: Introduction, Methods, Results, Discussion, Conclusion, and References. Exceptions are made for Reflection papers and Letters to the Editor.

In Reflection studies, sections should include: Introduction, Methods, Results and Discussion (with appropriate adaptations as needed by authors), Conclusion, and References.

Introduction: Clearly state the topic, relevant concepts, justification, knowledge gaps, and end with the study objective

Methods: Provide a complete description of the methodology, including study type, setting, population/sample, inclusion/exclusion criteria, data collection instrument (including validity and reliability), selected variables, data collection and analysis techniques (including statistical methods), and ethical procedures (include ethics approval number or equivalent from the country of origin).

Results: Limit to presenting findings, without interpretation or commentary. May include up to five illustrations (tables, graphs, figures, photographs) inserted in the text.

Discussion: Separate from results, should focus on data obtained, discussing them in light of national and international literature, highlighting new or significant aspects, and identifying study limitations and contributions.

Conclusion: A clear, concise statement that answers the objective, grounded in the results and consistent with the title and methods.

Para citações indiretas deve ser utilizado sistema numérico na identificação dos autores mencionados, de acordo com a ordem em que forem citados no texto, sem menção do nome dos autores. Os números que identificam os autores devem ser indicados sobrescritos e entre parênteses e após o ponto final. Se forem sequenciais, deverão ser indicados o primeiro e o último, separados por hífen (Ex.: (1-4)); quando intercalados, os números deverão ser separados por vírgula (Ex.:(1-2,4)).

Citation Format

• Indirect citations should use a numeric system according to the order cited, without author names. Citation numbers should be in superscript and in parentheses after the period (e.g., (1-4), (1-2,4)).
• Direct quotations must be in the body text, in quotation marks, including reference number and page (e.g., (1:30-31)).
• Testimonials should appear in font size 11, single-spaced, without italics or quotation marks, indented 2 cm, and identified using coded labels in parentheses. Omissions must be indicated by ellipses in brackets.

Illustrations (tables, graphs, figures) must not exceed five per manuscript, be numbered sequentially with Arabic numerals, and appear in the order cited. Each must include a title with location, state acronym, country, and year of data collection, using lowercase letters and single spacing. If not created by the authors, the source must be indicated.

References should appear at the end of the manuscript, include only those cited in the text, and follow Vancouver Style, as recommended by ICMJE (http://www.nlm.nih.gov/bsd/uniform_requirements.html). Journals should be abbreviated according to the NLM Catalog (https://www.ncbi.nlm.nih.gov/nlmcatalog/journals) or BVS (http://portal.revistas.bvs.br/). Authors must ensure:

Recomenda-se que autores considerem as seguintes exigências:

• At least 50% of references are from the last 5 years, and 30% from the last 2 years;
• At least 30% of references are from articles indexed in international databases;
• At least two references from REUFPI;
• References must be relevant and fully consulted by the authors;
• References should be in English when available;
• Avoid grey literature (official documents, theses, books, legislation, etc.), unless essential;
• REUFPI encourages citations with DOI;
• If DOI is unavailable, provide full URL and access date;
• Up to three preprint references are allowed;
• Authors are responsible for reference accuracy;
• Appendices and annexes should be avoided.

Examples of References:

Article with DOI:
Silva MDF, Gouveia MTO, Fernandes MA, Costa RS. Estratégias de enfrentamento do estresse utilizados por enfermeiros em maternidade. Rev Enferm UFPI. [Internet]. 2020;9(1):178-82. doi: https://doi.org/10.26694/reufpi.v9i0.9153

Electronic article:
Silva Júnior FJG, Santos LCS, Moura PVS, Melo BMS, Monteiro CFS. Processo de morte e morrer: evidências da literatura científica de enfermagem. Rev bras enferm. [Internet]. 2011;64(6):1122-6. Available from: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0034-71672011000600020&lng=pt

Preprint:
Santos-López M, Jaque-Ulloa D, Serrano-Aliste S. Métodos de Desinfección y Reutilización de Mascarillas con Filtro Respirador Durante la Pandemia de SARS-CoV-2. Int J Odontostomat. 2020;14(3):310-5. doi: http://dx.doi.org/10.4067/S0718-381X2020000300310

Institutional author:
Brazil. Ministry of Health. Health Surveillance Secretariat. Department of Epidemiological Surveillance. Epidemiological Surveillance Guide. 7th ed. Brasília: Ministry of Health; 2009.

Books:
Nunes BMVT, Santos AMR, editors. História da Associação Brasileira de Enfermagem seção Piauí: 50 anos de responsabilidade ético-social. Teresina (PI): ABEn; 2009.

Book chapter:
Moreira ICCC, Monteiro CFS, Magalhães RLB, Oliveira ADS, Melo BMS. The nurse facing situations of violence against women. In: Leite MMJ, general coordination; Martini JG, Felli VEA, editors. Programa de Atualização em Enfermagem: saúde do adulto (PROENF). 1st ed. Associação Brasileira de Enfermagem – Porto Alegre (RS): Artmed/Panamericana; 2010. p. 87-105.

Empirical, experimental, or conceptual research with a rigorous method, unpublished results, in-depth discussion, and contribution to national and international scientific literature. Qualitative studies are also considered. Limit: 15 pages including abstract, tables, figures, and references.

Results of integrative, scoping, or systematic reviews, with or without meta-analysis or meta-synthesis. Must include research question, inclusion/exclusion criteria, sampling/literature search, extracted data, quality assessment, and knowledge synthesis. Limit: 20 pages.

Descriptions of teaching, outreach, care experiences, or technological innovation products. Limit: 12 pages.

Theoretical and critical discussion on relevant Nursing topics. Must analyze theoretical/practical perspectives. Limit: 12 pages.

Theoretical and critical discussion of a research method or technique relevant to Nursing and related fields. It has a narrative and reflective nature. The manuscript should present theoretical and/or practical perspectives that clarify best research practices for producing robust scientific results. Maximum length: 12 pages, including abstract and references.

Description of the planning of multicenter clinical trials, robust epidemiological studies, systematic reviews, or scoping reviews. Submission of protocol manuscripts is encouraged at an early stage of the study. If data collection is already complete, the manuscript will not be considered. The publication of study protocols allows researchers and funding agencies to stay updated in their fields, providing visibility to research activities that would otherwise not be widely disseminated. For clinical trial protocols, authors must follow the SPIRIT (Standard Protocol Items for Randomized Trials) guidelines. Registration is mandatory for clinical trial protocols. For studies conducted in Brazil, registration in ReBEC (Brazilian Clinical Trials Registry) or another recognized clinical trial repository is required. The registration number must be reported in the manuscript. Maximum length: 12 pages, including abstract and references.

Comments on recently published articles, expressing agreement/disagreement or presenting significant findings. Limit: 2 pages.

Names and addresses entered in this journal will be used exclusively for the services provided by this publication and will not be made available for other purposes or to third parties.